2mg Glycomet GP Metformin Hydrochloride Sustained Release And Glimepiride Tablets

Glycomet GP 2 mg Tablet – Description

Glycomet GP 2 mg is a combination oral antidiabetic medicine containing Metformin Hydrochloride Sustained Release and Glimepiride. It is used along with a suitable diet and regular physical activity to help manage Type 2 diabetes mellitus when lifestyle measures alone are not sufficient.

Metformin Hydrochloride SR helps reduce glucose production by the liver and improves the body's sensitivity to insulin, while Glimepiride helps the pancreas release insulin, supporting better blood-glucose control.

Key Features:

• Combination of Metformin Hydrochloride Sustained Release and Glimepiride
• Helps control elevated blood glucose levels in Type 2 diabetes
• Sustained-release formulation of Metformin
• Intended for use under medical supervision
• Should be taken according to the prescribed dosage and schedule

Important: This medicine may cause low blood sugar, particularly when meals are skipped or when used with other glucose-lowering medicines. Common side effects may include nausea, diarrhea, stomach discomfort, or headache. It should be used only as directed by a qualified healthcare professional.